A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
- Status
- WITHDRAWN
- Phase
- PHASE3
Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
- Status
- UNKNOWN
- Phase
- N/A
Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
- Status
- COMPLETED
- Phase
- PHASE2
Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE4
Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD
- Status
- COMPLETED
- Phase
- N/A
Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
- Status
- TERMINATED
- Phase
- PHASE3
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
- Status
- COMPLETED
- Phase
- PHASE3